Global Severe Asthma Treatment Market Poised For Significant Growth To Reach USD 36.18 Billion By 2033: FMI Study
North America severe asthma market is set for growth, driven by high asthma prevalence, increased awareness, and advanced treatment options for severe cases. Ankush Nikam Future Market Insights, Inc.
Future Market Insights4d
Pharmaceutical Filtration Industry to Reach USD 45.08 Billion by 2033 at a CAGR of 8.9%
The global Pharmaceutical Filtration Market is set to experience robust growth over the next decade. Currently valued at US$ ...
Future Market Insights6d
Proteinase K Industry to Reach USD 43.9 Million by 2033, Growing at a Steady CAGR of 4.8%
The global proteinase K market is projected to grow from US$ 27.5 million in 2023 to US$ 43.9 million by 2033, at a CAGR of 4 ...
Business Insider4d
Mersana Therapeutics: Promising Clinical Data and Strong Financial Position Justify Buy Rating
Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target at $8.00. Discover outperforming stocks and invest ...
Business Insider4d
Rapport Therapeutics, Inc. (RAPP) Receives a Buy from TD Cowen
In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report). The company’s shares closed last Wednesday at $16.69.
Yahoo Finance5d
Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries
NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative, patient-focused treatments, today responded to recent ...
Global Fertility Supplement Market to Grow at 8.4% CAGR Amid Rising Infertility Rates from 2025 to 2035 | Future Market Insights, Inc.
Fertility supplements have been found to aid in increasing fertility rates, healthy pregnancy, and boosting delivery by ...
STAT6d
Denali Therapeutics spinout raises $200M as neuro company resets
A new company is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug candidates and raising money from one of its original investors. The biotech ...
The Irish News4d
“Armagh beat Derry, Kerry and Galway. You can be lucky once; you’re not lucky three times” - Armagh great Stevie McDonnell ponders 2025
THE legendary Stevie McDonnell doesn’t buy into the notion that Armagh were lucky to win last year’s All-Ireland - and insists Kieran McGeeney’s men won’t be derailed by a raft of new ...
Mena FN6d
Tenvie Therapeutics Launches With $200 Million To Deliver Breakthrough Small Molecule Therapies
Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tenvie Therapeutics launched today with a commitment to transform the treatment of neurological diseases. The company combines a deep and diverse portfolio of ...
MM&M4d
Rx Rundown: Verdiva, Johnson & Johnson, Transcarent and more
OMNY Health is partnering with Scipher Medicine. Vertex Pharmaceuticals signed a three-year deal with Orna Therapeutics to use the RNA biotech’s delivery particles to develop its next iteration of ...
FierceBiotech6d
Arch-backed Tenvie unveils with $200M and a neuro pipeline with assets from Denali
Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing several programs—and an executive—from Denali Therapeutics.